NOVT vs TRS
NOVT: Novanta supplies precision motion control, optics, and specialty components to medical device, life science, and advanced industrial OEMs globally. TRS: TriMas manufactures innovative dispensing closures, packaging solutions, and specialty industrial products for consumer, aerospace, and defense markets worldwide.
Side-by-side fundamentals
| Metric | NOVT | TRS | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $140.80 | $40.56 | |
| Market cap as of 2026-07-31 | $5.0B | $1.5B | |
| P/E as of 2026-07-31 | 92.86 | 1.55 | TRS lower |
| PEG as of 2026-07-31 | n/a | 0.00 | |
| Net margin as of 2026-07-31 | +5.3% | +116.1% | TRS higher |
| Gross margin as of 2026-07-31 | +44.2% | +24.2% | NOVT higher |
| Operating margin as of 2026-07-31 | +8.9% | +7.1% | NOVT higher |
| ROE as of 2026-07-31 | +5.1% | +85.8% | TRS higher |
| ROA as of 2026-07-31 | +3.2% | +47.9% | TRS higher |
| Debt / equity as of 2026-07-31 | 0.19 | 0.27 | NOVT lower |
| Revenue growth (YoY) as of 2026-07-31 | +5.6% | -24.2% | NOVT higher |
| Revenue CAGR (3y) SEC XBRL | +4.4% | -9.9% | NOVT higher |
| Dividend yield as of 2026-07-31 | n/a | +0.4% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-31 | 1.70 | 0.62 | |
| 1-year return as of 2026-07-27 close | +10.7% | +29.0% | TRS higher |
Fundamentals: market data, as of 2026-07-31. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.